Last 12 months
Inside the activity.
6 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 6 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 28, 2025 Filed Dec 30, 2025 21:17 UTC |
Wilson Charles JosephEVP and COO
|
Exercise / conversionCommon Stock | 160 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001170010-25-000137 · wk-form4_1767129466.xml · nonDerivative · entry 1 Wilson Charles Joseph · CIK 0001721932 · EVP and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,562 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), the Reporting Person received approximately 0.6377 times the number of MSUs in shares of Company common stock. Read SEC document |
| December 26, 2025 Filed Dec 30, 2025 21:17 UTC |
McCreight David W.Director · Interim President and CEO
|
GrantRestricted Stock Units · Derivative | 91,673 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001170010-25-000136 · wk-form4_1767129459.xml · derivative · entry 1 McCreight David W. · CIK 0001440360 · Director · Interim President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,673 Underlying: Common Stock · 91,673 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Common Stock. The restricted stock units shall vest on December 26, 2026, subject to earlier vesting in accordance with the terms of the Form of Notice of Restricted Stock Unit Grant between CarMax, Inc. and certain employee directors of the CarMax, Inc. board of directors, filed as Exhibit 10.3 to the Company's Quarterly Report on December 23, 2025. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Common Stock. The restricted stock units shall vest on December 26, 2026, subject to earlier vesting in accordance with the terms of the Form of Notice of Restricted Stock Unit Grant between CarMax, Inc. and certain employee directors of the CarMax, Inc. board of directors, filed as Exhibit 10.3 to the Company's Quarterly Report on December 23, 2025. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Common Stock. The restricted stock units shall vest on December 26, 2026, subject to earlier vesting in accordance with the terms of the Form of Notice of Restricted Stock Unit Grant between CarMax, Inc. and certain employee directors of the CarMax, Inc. board of directors, filed as Exhibit 10.3 to the Company's Quarterly Report on December 23, 2025. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Common Stock. The restricted stock units shall vest on December 26, 2026, subject to earlier vesting in accordance with the terms of the Form of Notice of Restricted Stock Unit Grant between CarMax, Inc. and certain employee directors of the CarMax, Inc. board of directors, filed as Exhibit 10.3 to the Company's Quarterly Report on December 23, 2025. Read SEC document |
| December 26, 2025 Filed Dec 30, 2025 21:17 UTC |
FOLLIARD THOMAS JDirector · Interim Executive Chair
|
GrantRestricted Stock Units · Derivative | 25,465 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001170010-25-000135 · wk-form4_1767129451.xml · derivative · entry 1 FOLLIARD THOMAS J · CIK 0001223841 · Director · Interim Executive Chair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,465 Underlying: Common Stock · 25,465 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Common Stock. The restricted stock units shall vest on December 26, 2026, subject to earlier vesting in accordance with the terms of the Form of Notice of Restricted Stock Unit Grant between CarMax, Inc. and certain employee directors of the CarMax, Inc. board of directors, filed as Exhibit 10.3 to the Company's Quarterly Report on December 23, 2025. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Common Stock. The restricted stock units shall vest on December 26, 2026, subject to earlier vesting in accordance with the terms of the Form of Notice of Restricted Stock Unit Grant between CarMax, Inc. and certain employee directors of the CarMax, Inc. board of directors, filed as Exhibit 10.3 to the Company's Quarterly Report on December 23, 2025. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Common Stock. The restricted stock units shall vest on December 26, 2026, subject to earlier vesting in accordance with the terms of the Form of Notice of Restricted Stock Unit Grant between CarMax, Inc. and certain employee directors of the CarMax, Inc. board of directors, filed as Exhibit 10.3 to the Company's Quarterly Report on December 23, 2025. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Common Stock. The restricted stock units shall vest on December 26, 2026, subject to earlier vesting in accordance with the terms of the Form of Notice of Restricted Stock Unit Grant between CarMax, Inc. and certain employee directors of the CarMax, Inc. board of directors, filed as Exhibit 10.3 to the Company's Quarterly Report on December 23, 2025. Read SEC document |
| October 16, 2025 Filed Dec 30, 2025 21:17 UTC |
Wilson Charles JosephEVP and COO
|
OtherCommon Stock | 527 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-25-000137 · wk-form4_1767129466.xml · nonDerivative · entry 3 Wilson Charles Joseph · CIK 0001721932 · EVP and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,040 Read SEC document |
| October 02, 2025 Filed Oct 3, 2025 20:09 UTC |
STEENROD MITCHELL DDirector
|
PurchaseCommon Stock | 2,000 | $45.57 | $91,140.00 |
DisclosureSEC source: 0001170010-25-000121 · wk-form4_1759522157.xml · nonDerivative · entry 1 STEENROD MITCHELL D · CIK 0001511361 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,330 Read SEC document |
| October 02, 2025 Filed Oct 6, 2025 20:11 UTC |
ONeil Mark FDirector
|
PurchaseCommon Stock | 10,816 | $46.21 | $499,807.36 |
DisclosureSEC source: 0001170010-25-000123 · wk-form4_1759781467.xml · nonDerivative · entry 1 ONeil Mark F · CIK 0001342016 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,690 F1 · price: The shares with respect to this transaction were purchased at prices ranging from $46.19 to $46.21. Upon request, the Reporting Person will provide the Securities and Exchange Commission staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| July 08, 2025 Filed Jul 9, 2025 20:23 UTC |
Stuckey John M IIISVP, Gen Counsel & Secretary
|
GiftCommon Stock | 70 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-25-000113 · wk-form4_1752092603.xml · nonDerivative · entry 1 Stuckey John M III · CIK 0002030154 · SVP, Gen Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,667 F1 · balance_after: Shares reported reflect .6775 fractional share rounded to the next full share. Read SEC document |
| July 07, 2025 Filed Jul 7, 2025 20:58 UTC |
Stuckey John M IIISVP, Gen Counsel & Secretary
|
GiftCommon Stock | 15 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-25-000111 · wk-form4_1751921881.xml · nonDerivative · entry 3 Stuckey John M III · CIK 0002030154 · SVP, Gen Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,737 Read SEC document |
| July 03, 2025 Filed Jul 7, 2025 20:58 UTC |
Stuckey John M IIISVP, Gen Counsel & Secretary
|
GiftCommon Stock | 20 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-25-000111 · wk-form4_1751921881.xml · nonDerivative · entry 2 Stuckey John M III · CIK 0002030154 · SVP, Gen Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,752 Read SEC document |
| July 02, 2025 Filed Jul 3, 2025 20:11 UTC |
Daniels Jon GEVP, CAF
|
SaleCommon Stock | 1,540 | $70.64 | $108,785.60 |
DisclosureSEC source: 0001170010-25-000108 · wk-form4_1751573493.xml · nonDerivative · entry 1 Daniels Jon G · CIK 0001628337 · EVP, CAF 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,779 Read SEC document |
| July 02, 2025 Filed Jul 7, 2025 20:58 UTC |
Stuckey John M IIISVP, Gen Counsel & Secretary
|
GiftCommon Stock | 55 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-25-000111 · wk-form4_1751921881.xml · nonDerivative · entry 1 Stuckey John M III · CIK 0002030154 · SVP, Gen Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,772 Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 20:23 UTC |
Cafritz Diane LEVP, Chief Innov & People Off
|
GrantStock Options (Right to Buy) · Derivative | 3,685 | $0.00 Strike: $67.21 | $0.00 |
DisclosureSEC source: 0001170010-25-000106 · wk-form4_1751487773.xml · derivative · entry 2 Cafritz Diane L · CIK 0001702741 · EVP, Chief Innov & People Off 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,685 Underlying: Common Stock · 3,685 shares Expires 2032-06-30 F3 · security: The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options. F4 · derivative.exercise_date: The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of June 30, 2026, June 30, 2027, June 30, 2028 and June 30, 2029. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 20:23 UTC |
Cafritz Diane LEVP, Chief Innov & People Off
|
GrantRestricted Stock Units · Derivative | 1,066 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-25-000106 · wk-form4_1751487773.xml · derivative · entry 1 Cafritz Diane L · CIK 0001702741 · EVP, Chief Innov & People Off 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,066 Underlying: Common Stock · Not disclosed shares Expires not disclosed F1 · derivative.exercise_price: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.22 to the Company's Annual Report on Form 10-K filed on April 15, 2024. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. F2 · derivative.exercise_date: The restricted stock units shall vest on June 30, 2028. F1 · derivative.expiration_date: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.22 to the Company's Annual Report on Form 10-K filed on April 15, 2024. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. F2 · derivative.expiration_date: The restricted stock units shall vest on June 30, 2028. F1 · derivative.underlying_shares: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.22 to the Company's Annual Report on Form 10-K filed on April 15, 2024. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 20:21 UTC |
ONeil Mark FDirector
|
GrantCommon Stock | 2,753 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-25-000105 · wk-form4_1751487685.xml · nonDerivative · entry 1 ONeil Mark F · CIK 0001342016 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,874 Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 20:21 UTC |
McCreight David W.Director
|
GrantCommon Stock | 2,753 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-25-000104 · wk-form4_1751487671.xml · nonDerivative · entry 1 McCreight David W. · CIK 0001440360 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,699 Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 20:21 UTC |
Goodman ShiraDirector
|
GrantCommon Stock | 2,753 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-25-000103 · wk-form4_1751487657.xml · nonDerivative · entry 1 Goodman Shira · CIK 0001199915 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,325 Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 20:20 UTC |
STEENROD MITCHELL DDirector
|
GrantCommon Stock | 2,753 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-25-000102 · wk-form4_1751487645.xml · nonDerivative · entry 1 STEENROD MITCHELL D · CIK 0001511361 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,330 Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 20:20 UTC |
Shinder MarcellaDirector
|
GrantCommon Stock | 2,753 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-25-000101 · wk-form4_1751487632.xml · nonDerivative · entry 1 Shinder Marcella · CIK 0001639923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,419 Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 20:20 UTC |
Chawla SonaDirector
|
GrantCommon Stock | 2,753 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-25-000100 · wk-form4_1751487620.xml · nonDerivative · entry 1 Chawla Sona · CIK 0001438864 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,702 Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 20:20 UTC |
Satriano PietroDirector
|
GrantCommon Stock | 2,753 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-25-000099 · wk-form4_1751487610.xml · nonDerivative · entry 1 Satriano Pietro · CIK 0001675303 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,315 Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 20:20 UTC |
Bensen Peter JDirector
|
GrantCommon Stock | 2,753 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-25-000098 · wk-form4_1751487597.xml · nonDerivative · entry 1 Bensen Peter J · CIK 0001395526 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,296 Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 20:19 UTC |
FOLLIARD THOMAS JDirector
|
GrantCommon Stock | 2,753 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-25-000097 · wk-form4_1751487585.xml · nonDerivative · entry 1 FOLLIARD THOMAS J · CIK 0001223841 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 212,821 Read SEC document |
| May 02, 2025 Filed May 5, 2025 20:14 UTC |
Cafritz Diane LEVP, Chief Innov & People Off
|
Tax withholdingCommon Stock | 977 | $66.71 | $65,175.67 |
DisclosureSEC source: 0001170010-25-000062 · wk-form4_1746476047.xml · nonDerivative · entry 1 Cafritz Diane L · CIK 0001702741 · EVP, Chief Innov & People Off 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,579 Read SEC document |
| May 02, 2025 Filed May 5, 2025 20:14 UTC |
Mayor-Mora Enrique NEVP & CFO
|
Tax withholdingCommon Stock | 1,200 | $66.71 | $80,052.00 |
DisclosureSEC source: 0001170010-25-000061 · wk-form4_1746476035.xml · nonDerivative · entry 1 Mayor-Mora Enrique N · CIK 0001793012 · EVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,883 Read SEC document |
| May 02, 2025 Filed May 5, 2025 20:13 UTC |
Daniels Jon GEVP, CAF
|
Tax withholdingCommon Stock | 655 | $66.71 | $43,695.05 |
DisclosureSEC source: 0001170010-25-000060 · wk-form4_1746476024.xml · nonDerivative · entry 1 Daniels Jon G · CIK 0001628337 · EVP, CAF 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,319 Read SEC document |
| May 02, 2025 Filed May 5, 2025 20:13 UTC |
Livesay Jill AVP, Controller & PAO
|
Exercise / conversionRestricted Stock Units · Derivative | 1,414 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-25-000059 · wk-form4_1746476013.xml · derivative · entry 5 Livesay Jill A · CIK 0001456533 · VP, Controller & PAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,100 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), the Reporting Person received 0.7777 times the number of MSUs in shares of Company common stock. F6 · derivative.exercise_date: The restricted stock units vested on May 2, 2025 and were settled in Company common stock. F6 · derivative.expiration_date: The restricted stock units vested on May 2, 2025 and were settled in Company common stock. Read SEC document |
| May 02, 2025 Filed May 5, 2025 20:13 UTC |
Livesay Jill AVP, Controller & PAO
|
Tax withholdingCommon Stock | 332 | $66.71 | $22,147.72 |
DisclosureSEC source: 0001170010-25-000059 · wk-form4_1746476013.xml · nonDerivative · entry 2 Livesay Jill A · CIK 0001456533 · VP, Controller & PAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,216 Read SEC document |
| May 02, 2025 Filed May 5, 2025 20:13 UTC |
Livesay Jill AVP, Controller & PAO
|
Exercise / conversionCommon Stock | 1,100 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001170010-25-000059 · wk-form4_1746476013.xml · nonDerivative · entry 1 Livesay Jill A · CIK 0001456533 · VP, Controller & PAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,548 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), the Reporting Person received 0.7777 times the number of MSUs in shares of Company common stock. Read SEC document |
| May 02, 2025 Filed May 5, 2025 20:13 UTC |
Nash William DDirector · President & CEO
|
Tax withholdingCommon Stock | 8,291 | $66.71 | $553,092.61 |
DisclosureSEC source: 0001170010-25-000058 · wk-form4_1746476003.xml · nonDerivative · entry 1 Nash William D · CIK 0001545342 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 206,731 Read SEC document |
| May 02, 2025 Filed May 5, 2025 20:12 UTC |
Shamim MohammadEVP and CITO
|
Tax withholdingCommon Stock | 1,023 | $66.71 | $68,244.33 |
DisclosureSEC source: 0001170010-25-000057 · wk-form4_1746475913.xml · nonDerivative · entry 1 Shamim Mohammad · CIK 0001620490 · EVP and CITO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,538 Read SEC document |
| May 02, 2025 Filed May 5, 2025 20:11 UTC |
Stuckey John M IIISVP, Gen Counsel & Secretary
|
Exercise / conversionRestricted Stock Units · Derivative | 1,579 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-25-000056 · wk-form4_1746475899.xml · derivative · entry 4 Stuckey John M III · CIK 0002030154 · SVP, Gen Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,228 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), the Reporting Person received 0.7777 times the number of MSUs in shares of Company common stock. F4 · derivative.exercise_date: The restricted stock units vested on May 2, 2025 and were settled in Company common stock. F4 · derivative.expiration_date: The restricted stock units vested on May 2, 2025 and were settled in Company common stock. Read SEC document |
| May 02, 2025 Filed May 5, 2025 20:11 UTC |
Stuckey John M IIISVP, Gen Counsel & Secretary
|
Tax withholdingCommon Stock | 370 | $66.71 | $24,682.70 |
DisclosureSEC source: 0001170010-25-000056 · wk-form4_1746475899.xml · nonDerivative · entry 2 Stuckey John M III · CIK 0002030154 · SVP, Gen Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,827 Read SEC document |
| May 02, 2025 Filed May 5, 2025 20:11 UTC |
Stuckey John M IIISVP, Gen Counsel & Secretary
|
Exercise / conversionCommon Stock | 1,228 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001170010-25-000056 · wk-form4_1746475899.xml · nonDerivative · entry 1 Stuckey John M III · CIK 0002030154 · SVP, Gen Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,197 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), the Reporting Person received 0.7777 times the number of MSUs in shares of Company common stock. Read SEC document |
| May 02, 2025 Filed May 5, 2025 20:11 UTC |
Wilson Charles JosephEVP and COO
|
Tax withholdingCommon Stock | 662 | $66.71 | $44,162.02 |
DisclosureSEC source: 0001170010-25-000055 · wk-form4_1746475887.xml · nonDerivative · entry 1 Wilson Charles Joseph · CIK 0001721932 · EVP and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,402 Read SEC document |
| May 02, 2025 Filed May 5, 2025 20:11 UTC |
Tuite TylerSVP & Chief Product Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,161 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-25-000054 · wk-form4_1746475872.xml · derivative · entry 4 Tuite Tyler · CIK 0002028856 · SVP & Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 903 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), the Reporting Person received 0.7777 times the number of MSUs in shares of Company common stock. F4 · derivative.exercise_date: The restricted stock units vested on May 2, 2025 and were settled in Company common stock. F4 · derivative.expiration_date: The restricted stock units vested on May 2, 2025 and were settled in Company common stock. Read SEC document |
| May 02, 2025 Filed May 5, 2025 20:11 UTC |
Tuite TylerSVP & Chief Product Officer
|
Tax withholdingCommon Stock | 272 | $66.71 | $18,145.12 |
DisclosureSEC source: 0001170010-25-000054 · wk-form4_1746475872.xml · nonDerivative · entry 2 Tuite Tyler · CIK 0002028856 · SVP & Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 858 Read SEC document |
| May 02, 2025 Filed May 5, 2025 20:11 UTC |
Tuite TylerSVP & Chief Product Officer
|
Exercise / conversionCommon Stock | 903 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001170010-25-000054 · wk-form4_1746475872.xml · nonDerivative · entry 1 Tuite Tyler · CIK 0002028856 · SVP & Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,130 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), the Reporting Person received 0.7777 times the number of MSUs in shares of Company common stock. Read SEC document |
| May 02, 2025 Filed May 5, 2025 20:11 UTC |
Lyski JamesEVP, Chief Growth & Strat Off
|
Tax withholdingCommon Stock | 1,444 | $66.71 | $96,329.24 |
DisclosureSEC source: 0001170010-25-000053 · wk-form4_1746475859.xml · nonDerivative · entry 1 Lyski James · CIK 0001376853 · EVP, Chief Growth & Strat Off 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,164 Read SEC document |
| May 01, 2025 Filed May 5, 2025 20:14 UTC |
Cafritz Diane LEVP, Chief Innov & People Off
|
GrantStock Options (Right to Buy) · Derivative | 35,265 | $0.00 Strike: $65.52 | $0.00 |
DisclosureSEC source: 0001170010-25-000062 · wk-form4_1746476047.xml · derivative · entry 2 Cafritz Diane L · CIK 0001702741 · EVP, Chief Innov & People Off 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,265 Underlying: Common Stock · 35,265 shares Expires 2032-05-01 F1 · security: The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options. F2 · derivative.exercise_date: The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 1, 2026, May 1, 2027, May 1, 2028 and May 1, 2029. Read SEC document |
| May 01, 2025 Filed May 5, 2025 20:14 UTC |
Mayor-Mora Enrique NEVP & CFO
|
GrantStock Options (Right to Buy) · Derivative | 39,077 | $0.00 Strike: $65.52 | $0.00 |
DisclosureSEC source: 0001170010-25-000061 · wk-form4_1746476035.xml · derivative · entry 2 Mayor-Mora Enrique N · CIK 0001793012 · EVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,077 Underlying: Common Stock · 39,077 shares Expires 2032-05-01 F1 · security: The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options. F2 · derivative.exercise_date: The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 1, 2026, May 1, 2027, May 1, 2028 and May 1, 2029. Read SEC document |
| May 01, 2025 Filed May 5, 2025 20:13 UTC |
Daniels Jon GEVP, CAF
|
GrantStock Options (Right to Buy) · Derivative | 30,499 | $0.00 Strike: $65.52 | $0.00 |
DisclosureSEC source: 0001170010-25-000060 · wk-form4_1746476024.xml · derivative · entry 2 Daniels Jon G · CIK 0001628337 · EVP, CAF 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,499 Underlying: Common Stock · 30,499 shares Expires 2032-05-01 F1 · security: The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options. F2 · derivative.exercise_date: The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 1, 2026, May 1, 2027, May 1, 2028 and May 1, 2029. Read SEC document |
| May 01, 2025 Filed May 5, 2025 20:13 UTC |
Livesay Jill AVP, Controller & PAO
|
GrantRestricted Stock Units · Derivative | 4,139 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-25-000059 · wk-form4_1746476013.xml · derivative · entry 4 Livesay Jill A · CIK 0001456533 · VP, Controller & PAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,139 Underlying: Common Stock · Not disclosed shares Expires not disclosed F4 · derivative.exercise_price: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.22 to the Company's Annual Report on Form 10-K filed on April 15, 2024. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. F5 · derivative.exercise_date: The restricted stock units shall vest on May 1, 2028. F4 · derivative.expiration_date: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.22 to the Company's Annual Report on Form 10-K filed on April 15, 2024. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. F5 · derivative.expiration_date: The restricted stock units shall vest on May 1, 2028. F4 · derivative.underlying_shares: Shares of Company common stock will be issued to the Reporting Person following vesting of the restricted stock units, which are referred to by the Company as market stock units (MSUs), in accordance with the terms of the Form of Notice of Market Stock Unit Grant filed as Exhibit 10.22 to the Company's Annual Report on Form 10-K filed on April 15, 2024. The minimum number of shares of Company common stock that will be issued to the Reporting Person at payment is zero, and the maximum number of shares of Company common stock that will be issued at payment is two times the number of MSUs. Read SEC document |
| May 01, 2025 Filed May 5, 2025 20:13 UTC |
Livesay Jill AVP, Controller & PAO
|
GrantStock Options (Right to Buy) · Derivative | 14,513 | $0.00 Strike: $65.52 | $0.00 |
DisclosureSEC source: 0001170010-25-000059 · wk-form4_1746476013.xml · derivative · entry 3 Livesay Jill A · CIK 0001456533 · VP, Controller & PAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,513 Underlying: Common Stock · 14,513 shares Expires 2032-05-01 F2 · security: The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options. F3 · derivative.exercise_date: The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 1, 2026, May 1, 2027, May 1, 2028 and May 1, 2029. Read SEC document |
| May 01, 2025 Filed May 5, 2025 20:13 UTC |
Nash William DDirector · President & CEO
|
GrantStock Options (Right to Buy) · Derivative | 200,152 | $0.00 Strike: $65.52 | $0.00 |
DisclosureSEC source: 0001170010-25-000058 · wk-form4_1746476003.xml · derivative · entry 2 Nash William D · CIK 0001545342 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,152 Underlying: Common Stock · 200,152 shares Expires 2032-05-01 F1 · security: The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options. F2 · derivative.exercise_date: The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 1, 2026, May 1, 2027, May 1, 2028 and May 1, 2029. Read SEC document |
| May 01, 2025 Filed May 5, 2025 20:12 UTC |
Shamim MohammadEVP and CITO
|
GrantStock Options (Right to Buy) · Derivative | 35,265 | $0.00 Strike: $65.52 | $0.00 |
DisclosureSEC source: 0001170010-25-000057 · wk-form4_1746475913.xml · derivative · entry 2 Shamim Mohammad · CIK 0001620490 · EVP and CITO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,265 Underlying: Common Stock · 35,265 shares Expires 2032-05-01 F1 · security: The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options. F2 · derivative.exercise_date: The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 1, 2026, May 1, 2027, May 1, 2028 and May 1, 2029. Read SEC document |
| May 01, 2025 Filed May 5, 2025 20:11 UTC |
Stuckey John M IIISVP, Gen Counsel & Secretary
|
GrantStock Options (Right to Buy) · Derivative | 20,968 | $0.00 Strike: $65.52 | $0.00 |
DisclosureSEC source: 0001170010-25-000056 · wk-form4_1746475899.xml · derivative · entry 3 Stuckey John M III · CIK 0002030154 · SVP, Gen Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,968 Underlying: Common Stock · 20,968 shares Expires 2032-05-01 F2 · security: The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options. F3 · derivative.exercise_date: The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 1, 2026, May 1, 2027, May 1, 2028 and May 1, 2029. Read SEC document |
| May 01, 2025 Filed May 5, 2025 20:11 UTC |
Wilson Charles JosephEVP and COO
|
GrantStock Options (Right to Buy) · Derivative | 39,077 | $0.00 Strike: $65.52 | $0.00 |
DisclosureSEC source: 0001170010-25-000055 · wk-form4_1746475887.xml · derivative · entry 2 Wilson Charles Joseph · CIK 0001721932 · EVP and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,077 Underlying: Common Stock · 39,077 shares Expires 2032-05-01 F1 · security: The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options. F2 · derivative.exercise_date: The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 1, 2026, May 1, 2027, May 1, 2028 and May 1, 2029. Read SEC document |
| May 01, 2025 Filed May 5, 2025 20:11 UTC |
Tuite TylerSVP & Chief Product Officer
|
GrantStock Options (Right to Buy) · Derivative | 19,062 | $0.00 Strike: $65.52 | $0.00 |
DisclosureSEC source: 0001170010-25-000054 · wk-form4_1746475872.xml · derivative · entry 3 Tuite Tyler · CIK 0002028856 · SVP & Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,062 Underlying: Common Stock · 19,062 shares Expires 2032-05-01 F2 · security: The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options. F3 · derivative.exercise_date: The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 1, 2026, May 1, 2027, May 1, 2028 and May 1, 2029. Read SEC document |
| May 01, 2025 Filed May 5, 2025 20:11 UTC |
Lyski JamesEVP, Chief Growth & Strat Off
|
GrantStock Options (Right to Buy) · Derivative | 38,124 | $0.00 Strike: $65.52 | $0.00 |
DisclosureSEC source: 0001170010-25-000053 · wk-form4_1746475859.xml · derivative · entry 2 Lyski James · CIK 0001376853 · EVP, Chief Growth & Strat Off 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,124 Underlying: Common Stock · 38,124 shares Expires 2032-05-01 F1 · security: The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options. F2 · derivative.exercise_date: The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of May 1, 2026, May 1, 2027, May 1, 2028 and May 1, 2029. Read SEC document |
| April 24, 2025 Filed Apr 25, 2025 20:08 UTC |
STEENROD MITCHELL DDirector
|
PurchaseCommon Stock | 1,300 | $65.49 | $85,137.00 |
DisclosureSEC source: 0001170010-25-000042 · wk-form4_1745611714.xml · nonDerivative · entry 1 STEENROD MITCHELL D · CIK 0001511361 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,577 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.